CNR1 and Other metabolic disease: Metabolic disorders and associated comorbidities: Since both central and peripheral CB1Rs are involved in the regulation of appetite and metabolic processes, CB1R antagonism was investigated as a potential therapeutic opportunity for obesity and other metabolic disorders.